Synthesis of stable isotopically labelled internal standards for drug-drug interaction (DDI) studies

被引：0
|
作者：
Zimmermann, J. [1 ]
Allen, J. [2 ]
Atzrodt, J. [1 ]
De-Bruin, B. [2 ]
Derdau, V. [1 ]
Gantz, D. [1 ]
Herbert, J. [3 ]
Raddatz, S. [1 ]
Roy, S. [2 ]
机构：
[1] Sanofi Aventis, Global Isotope Chem & Metabollite Synthet Dept, D-65926 Frankfurt, Germany
[2] Sanofi Aventis, Global Isotope Chem & Metabollite Synthet Dept, F-91385 Chilly Mazarin, France
[3] Sanofi Aventis, Global Isotope Chem & Metabollite Synthet Dept, Ainwick NE66 2JH, England
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2007年 / 50卷 / 13-14期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1277 / 1278
页数：2
相关论文
共 50 条
  • [41] Drug-Drug Interaction Studies: Regulatory Guidance and An Industry Perspective
    Prueksaritanont, Thomayant
    Chu, Xiaoyan
    Gibson, Christopher
    Cui, Donghui
    Yee, Ka Lai
    Ballard, Jeanine
    Cabalu, Tamara
    Hochman, Jerome
    AAPS JOURNAL, 2013, 15 (03): : 629 - 645
  • [42] Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
    Andrea Treyer
    Mohammed Ullah
    Neil Parrott
    Birgit Molitor
    Stephen Fowler
    Per Artursson
    The AAPS Journal, 21
  • [43] Drug-Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
    Zurth, Christian
    Koskinen, Mikko
    Fricke, Robert
    Prien, Olaf
    Korjamo, Timo
    Graudenz, Kristina
    Denner, Karsten
    Bairlein, Michaela
    Von Buehler, Clemens-Jeremias
    Wilkinson, Gary
    Gieschen, Hille
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (06) : 747 - 759
  • [44] Microdosing Cocktail Assay Development for Drug-Drug Interaction Studies
    Chavez-Eng, Cynthia M.
    Lutz, Ryan W.
    Goykhman, Dina
    Bateman, Kevin P.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (07) : 1973 - 1986
  • [45] No Increased Risk of Ketoconazole Toxicity in Drug-Drug Interaction Studies
    Outeiro, Noemi
    Hohmann, Nicolas
    Mikus, Gerd
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (10): : 1203 - 1211
  • [46] Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies
    Treyer, Andrea
    Ullah, Mohammed
    Parrott, Neil
    Molitor, Birgit
    Fowler, Stephen
    Artursson, Per
    AAPS JOURNAL, 2019, 21 (05):
  • [47] In-vitro drug-drug interaction studies of diltiazem with floroquinolones
    Shafi, Nighat
    Siddiqui, Farhan Ahmed
    Arayne, Muhammad Saeed
    Sultana, Najma
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2017, 40 (20) : 1003 - 1014
  • [48] Understanding the Drug-Drug Interaction
    Yim, Dong-Seok
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2006, 49 (01): : 78 - 85
  • [49] HTCL-DDI: a hierarchical triple-view contrastive learning framework for drug-drug interaction prediction
    Zhang, Ran
    Wang, Xuezhi
    Wang, Pengfei
    Meng, Zhen
    Cui, Wenjuan
    Zhou, Yuanchun
    BRIEFINGS IN BIOINFORMATICS, 2023, 24 (06)
  • [50] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELING TO EVALUATE DRUG-DRUG INTERACTION (DDI) RISK OF ALECTINIB.
    Cleary, Y.
    Gertz, M.
    Morcos, P. N.
    Youdim, K.
    Fowler, S.
    Yu, L.
    Sekiguchi, N.
    Takanashi, K.
    Kaneko, A.
    Phipps, A.
    Parrott, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S40 - S40
12345